This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
17 results for: patents
post featured image
The Brazilian Patent and Trademark Office (BRPTO) efforts to reduce the patent backlog is generating positive results despite the...
post featured image
Language has been the biggest hurdle in the Unified Patent Court's creation since it was first mooted over 40 years ago. In the latest...
post featured image
For pharmaceutical companies, patent term extensions (PTEs) remain a fundamental means of compensating them for the erosion of the terms...
post featured image
Patent term extensions (PTEs) in Australia have been a hot topic over the past year.  On Friday, things got a lot hotter for patentees...
post featured image
In Europe, the unitary patent and the Unified Patent Court (UPC) have moved another step closer since Austria’s deposit of its...
post featured image
In its second significant recent decision addressing patent term extensions (PTEs) in Australia, the Federal Court of Australia, in Merck...
post featured image
SummaryIn a significant victory for pharmaceutical patentees, the Federal Court in Ono Pharmaceutical Co. Ltd v Commissioner of Patents...
post featured image
Artificial Intelligence (AI) and machine learning are increasingly used in the life sciences industry for research and drug discovery,...
post featured image
SummaryIn a significant victory for pharmaceutical patentees, the Federal Court in Ono Pharmaceutical Co. Ltd v Commissioner of Patents...
post featured image
The 2021-2022 Australian Federal Budget was unveiled last night (11 May 2021). Deemed the ‘COVID-19 Recovery Budget’, it includes a...
post featured image
In a pair of opinions issued in March, the Federal Circuit affirmed two Patent Trial and Appeal Board determinations that...
post featured image
It is always interesting to see how a Supreme Court judgment is applied in later cases, especially the first few times, and the High...
post featured image
I spent two fascinating days at the C5 Pharma and biotech conference last week. Some of the more interesting takeaways:in determining the...
post featured image
With the UK Supreme Court now considering its judgment on the future approach to second medical use patents in the UK, I am very much...
post featured image
How far does the new doctrine of equivalents introduced by the UK Supreme Court in Eli Lilly v Actavis really extend the scope of patent...
post featured image
The House of Lords Science and Technology Committee's inquiry into "Life Sciences and the Industrial Strategy" is fascinating.  Last week...